https://scholars.lib.ntu.edu.tw/handle/123456789/560671| Title: | Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry | Authors: | Ghofrani, Hossein-Ardeschir Gomez Sanchez, Miguel-Angel Humbert, Marc Pittrow, David Simonneau, Gérald Gall, Henning Grünig, Ekkehard Klose, Hans Halank, Michael Langleben, David Snijder, Repke J Escribano Subias, Pilar Mielniczuk, Lisa M Lange, Tobias J Vachiéry, Jean-Luc Wirtz, Hubert Helmersen, Douglas S Tsangaris, Iraklis Barberá, Joan A Pepke-Zaba, Joanna Boonstra, Anco Rosenkranz, Stephan Ulrich, Silvia Steringer-Mascherbauer, Regina Delcroix, Marion Jansa, Pavel Šimková, Iveta Giannakoulas, George Klotsche, Jens Williams, Evgenia Meier, Christian Hoeper, Marius M PING-HUNG KUO |
Keywords: | Chronic thromboembolic pulmonary hypertension; Clinical practice; Real-world; Registry; Riociguat; Safety;Chronic thromboembolic pulmonary hypertension; Clinical practice; Real-world; Registry; Riociguat; Safety | Issue Date: | 2021 | Journal Volume: | 178 | Source: | Respiratory medicine | Abstract: | The soluble guanylate cyclase stimulator riociguat is approved for the treatment of adult patients with pulmonary arterial hypertension (PAH) and inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) following Phase 3 randomized trials. The EXPosurE Registry RiociguaT in patients with pulmonary hypertension (EXPERT) study was designed to monitor the long-term safety of riociguat in clinical practice. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/560671 | ISSN: | 09546111 | DOI: | 10.1016/j.rmed.2020.106220 | SDG/Keyword: | ambrisentan; bosentan; guanylate cyclase; iloprost; macitentan; prostacyclin; prostanoid; riociguat; treprostinil; pyrazole derivative; pyrimidine derivative; riociguat; adverse event; aged; Article; chronic thromboembolic pulmonary hypertension; clinical practice; clinical trial; cohort analysis; combination drug therapy; disease registry; dizziness; drug safety; dyspnea; faintness; female; heart right ventricle failure; hemoptysis; human; hypotension; lung hemorrhage; major clinical study; male; Medical Dictionary for Regulatory Activities; monotherapy; multicenter study; peripheral edema; phase 3 clinical trial; pneumonia; priority journal; prospective study; pulmonary hypertension; randomized controlled trial; chronic disease; complication; data analysis; lung embolism; middle aged; multicenter study (topic); pulmonary hypertension; randomized controlled trial (topic); recurrent disease; register; safety; time factor; treatment outcome; Aged; Chronic Disease; Data Analysis; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Pulmonary Embolism; Pyrazoles; Pyrimidines; Randomized Controlled Trials as Topic; Recurrence; Registries; Safety; Time Factors; Treatment Outcome [SDGs]SDG3 |
| Appears in Collections: | 醫學院附設醫院 (臺大醫院) |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.